| Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma (NCT05964101) | The First Affiliated Hospital of Guangzhou Medical University | 2023-10-01 |
| A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD (NCT06003049) | RMW Testing | 2023-10-01 |
| Cartilage Recovery in Adults With Knee Osteorthritis by Mesenchymal Cell Therapy: Randomized Trial of Radiologic and Clinical Outcomes (NCT05936060) | GUSTAVO SALGUERO | 2023-10-01 |
| Efficacy and Safety of Astragalus for Non-motor Symptoms of α-Synucleinopathy (NCT05506891) | Fujian Medical University Union Hospital | 2023-10-01 |
| The Efficacy Of Lidocaine Infusion IN Chronic Unilateral Migraine Headache (NCT06109389) | Alexandria University | 2023-10-01 |
| Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus (NCT06010992) | Tanta University | 2023-10-01 |
| Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML (NCT06105658) | Anhui Provincial Hospital | 2023-10-01 |
| GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer (NCT06046274) | Genmab | 2023-10-01 |
| RCT of Ghrelin in Stroke Patients (NCT05726240) | Rijnstate Hospital | 2023-10-01 |
| MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib (NCT06075225) | Sichuan University | 2023-10-01 |
| Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation (NCT06045364) | Jie Chen | 2023-10-01 |
| Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer (NCT06094868) | Second Affiliated Hospital of Nanchang University | 2023-10-01 |
| Neoadjuvant SBRT in Localized Advanced HNSCC (NCT06306846) | Jiang Feng | 2023-10-01 |
| UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals (NCT04714060) | UBP Greater China (Shanghai) Co., Ltd | 2023-10-01 |
| Postoperative Oral Methadone After Major Spine Surgery; Safety, Feasibility and Efficacy in Prevention of Progression to Chronic Opioid Usage at 3 Months (NCT05693675) | The University of Texas Health Science Center, Houston | 2023-10-01 |
| Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients (NCT06703593) | British University In Egypt | 2023-10-01 |
| The Effect of Addition of Metformin In Obese Non- Diabetic Patients With Heart Failure With Preserved Ejection Fraction (NCT05847244) | Sara ElAdawy | 2023-10-01 |
| A Herbal Compound for Eczema (NCT06758752) | Fasa University of Medical Sciences | 2023-10-01 |
| Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy (NCT06072521) | Al-Azhar University | 2023-10-01 |
| Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis (NCT06033846) | Xijing Hospital | 2023-10-01 |
| Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NCT05975151) | Qilu Hospital of Shandong University | 2023-10-01 |
| Group MDMA-therapy for Veterans With PTSD (NCT05961527) | Portland VA Research Foundation, Inc | 2023-10-01 |
| Benralizumab in Chronic Prurigo - Investigating Clinical Efficacy (BICPIC) (NCT05528913) | Charite University, Berlin, Germany | 2023-10-01 |
| Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD) (NCT05879653) | Kyoto University Hospital | 2023-10-01 |
| Flapless Mini-incision Implant Surgery (NCT07008079) | Alaa Emara | 2023-10-01 |
| Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue (NCT05751720) | Dr Adnan Agha | 2023-10-01 |
| Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults (NCT06226077) | University of Minnesota | 2023-10-01 |
| Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC (NCT06100497) | Beijing Tongren Hospital | 2023-10-01 |
| A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors (NCT06092268) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2023-10-01 |
| Delayed Tolerance Through Mixed Chimerism (NCT05900401) | Massachusetts General Hospital | 2023-10-01 |
| Fruquintinib Plus FOLFIRI in RAS-mutated Metastatic Colorectal Cancer (NCT05842525) | Hunan Cancer Hospital | 2023-10-01 |
| Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease (NCT05709301) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2023-10-01 |
| Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease (NCT05969743) | Rabin Medical Center | 2023-10-01 |
| Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients (NCT06028633) | Peking University First Hospital | 2023-10-01 |
| A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL) (NCT04107961) | University of York | 2023-10-01 |
| IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC) (NCT06078657) | The First Affiliated Hospital of Zhengzhou University | 2023-10-01 |
| Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer (NCT06837792) | Yonsei University | 2023-10-01 |
| Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer (NCT05572476) | Institut Bergonié | 2023-10-01 |
| Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer (NCT06006104) | Jiangsu HengRui Medicine Co., Ltd. | 2023-09-30 |
| Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure (NCT05985863) | Beijing 302 Hospital | 2023-09-30 |
| An Open-Label, Single Center Phase 2 Study of Magrolimab, Rituximab and Radiation as Bridging Strategy Before CAR T-Cell Therapy in Patients With Relapsed or Refractory Large B-cell Lymphoma (NCT05929716) | M.D. Anderson Cancer Center | 2023-09-30 |
| Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC） (NCT06107673) | Hebei Medical University Fourth Hospital | 2023-09-30 |
| DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCC (NCT06055153) | Changhai Hospital | 2023-09-30 |
| MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach (NCT06050707) | University Health Network, Toronto | 2023-09-29 |
| Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer (NCT06062498) | Northwestern University | 2023-09-29 |
| TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma (NCT05980598) | Ascendis Pharma A/S | 2023-09-29 |
| A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD) (NCT06057012) | Brii Biosciences Limited | 2023-09-29 |
| Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome (NCT05933603) | University of Arizona | 2023-09-29 |
| Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness (NCT06110403) | University Hospital, Lille | 2023-09-29 |
| Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy (NCT05715229) | Hackensack Meridian Health | 2023-09-29 |
| Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010) (NCT06036836) | Merck Sharp & Dohme LLC | 2023-09-29 |
| Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells (NCT05705024) | University of Illinois at Chicago | 2023-09-29 |
| Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19 (NCT06057064) | AstraZeneca | 2023-09-29 |
| MEDical CANnabis for Improving Symptoms During Severe DEMentia Disorders in Long-term Care Facility in Geneva (NCT05432206) | Fondation pour l'accueil et l'hébérement des personnes âgées | 2023-09-29 |
| 90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia (NCT04856215) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2023-09-29 |
| Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca (NCT06008158) | City of Hope Medical Center | 2023-09-29 |
| Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia (NCT05417165) | Seema Bhat | 2023-09-29 |
| A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa (NCT06028230) | Sanofi | 2023-09-29 |
| A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight (NCT06151964) | AstraZeneca | 2023-09-29 |
| JAK/STAT Inhibition in CNS Kohlmeier-Degos Disease (NCT05998395) | National Heart, Lung, and Blood Institute (NHLBI) | 2023-09-28 |
| Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease (NCT06212089) | SNLD, Ltd. | 2023-09-28 |
| A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies (NCT05957367) | Deciphera Pharmaceuticals, LLC | 2023-09-28 |
| Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy (NCT05794321) | University of California, San Francisco | 2023-09-28 |
| Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT05920798) | Mayo Clinic | 2023-09-28 |
| Linezolid for Syphilis Pilot Study (NCT05548426) | University of Southern California | 2023-09-28 |
| To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH (NCT05997602) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2023-09-28 |
| Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc) (NCT06114004) | Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas | 2023-09-28 |
| 5-HTP and Creatine for Depression R33 Phase (NCT05895747) | University of Utah | 2023-09-28 |
| Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness (NCT05691491) | National Cancer Institute (NCI) | 2023-09-28 |
| A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome (NCT05979831) | Daiichi Sankyo | 2023-09-28 |
| Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort (NCT05693766) | Sonya Reid | 2023-09-28 |
| Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors (NCT06088004) | Suzhou Abogen Biosciences Co., Ltd. | 2023-09-28 |
| A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer (NCT05848011) | MacroGenics | 2023-09-28 |
| Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma (NCT06055816) | Zhejiang Cancer Hospital | 2023-09-28 |
| Siplizumab for Sickle Cell Disease Transplant (NCT06078696) | Columbia University | 2023-09-28 |
| Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis (NCT05824728) | Johns Hopkins University | 2023-09-28 |
| A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis (NCT06077331) | Hansoh BioMedical R&D Company | 2023-09-28 |
| Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab (NCT05744375) | Spanish Breast Cancer Research Group | 2023-09-28 |
| Cannabidiol Medication Intervention Trial (NCT06014424) | Sunnybrook Health Sciences Centre | 2023-09-27 |
| Effects Of A Probiotic Formulation On Stress and Skin Health in Younger Adult Females (NCT06057883) | Lallemand Health Solutions | 2023-09-27 |
| Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis (NCT06041919) | Thirty Respiratory Limited | 2023-09-27 |
| Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma (NCT06066333) | Memorial Sloan Kettering Cancer Center | 2023-09-27 |
| LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC (NCT05537402) | University of Texas Southwestern Medical Center | 2023-09-27 |
| 99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT (NCT05891769) | Andrei Iagaru | 2023-09-27 |
| Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke (NCT05363397) | The Florey Institute of Neuroscience and Mental Health | 2023-09-27 |
| Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia (NCT05128162) | Kevin Boehnke | 2023-09-27 |
| Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors (NCT05636618) | Perspective Therapeutics | 2023-09-27 |
| Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism (NCT05794165) | Bryan Cotton | 2023-09-27 |
| A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy (NCT06066346) | Memorial Sloan Kettering Cancer Center | 2023-09-27 |
| 9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer (NCT06079112) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2023-09-27 |
| Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes (NCT05979415) | Alexza Pharmaceuticals, Inc. | 2023-09-27 |
| Study of CYR-064 Versus Placebo in Patients. (NCT06019000) | Cyrano Therapeutics, Inc. | 2023-09-26 |
| First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations (NCT06043817) | Pierre Fabre Medicament | 2023-09-26 |
| Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial (NCT05715281) | National Cancer Institute (NCI) | 2023-09-26 |
| MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer (NCT05903092) | Hirva Mamdani | 2023-09-26 |
| A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause (NCT05812924) | University of Miami | 2023-09-26 |
| Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology (NCT05756569) | Emory University | 2023-09-26 |
| A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia (NCT05785819) | Veralox Therapeutics | 2023-09-26 |
| Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC (NCT06165900) | Shengjing Hospital | 2023-09-26 |
| Intradermal Administration of a COVID-19 mRNA Vaccine in Elderly (NCT05977127) | Radboud University Medical Center | 2023-09-26 |